LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

LB195 Actions
Date Description Journal Vote
Jan 16, 2025 Notice of hearing for January 23, 2025 230
Jan 16, 2025 Referred to Judiciary Committee 205
Jan 14, 2025 Date of introduction 157